| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.32 | 1e-09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |